Isotretinoin; A review on the Utilization Pattern in Pregnancy

Sajad Khiali ¹ , Afshin Gharekhani ² , Taher Entezari-Maleki ² *

Cited by CrossRef: 14

1- Ibrahim S, Gaborit B, Lenoir M, Collod-Beroud G, Stefanovic S. Maternal Pre-Existing Diabetes: A Non-Inherited Risk Factor for Congenital Cardiopathies. IJMS. 2023;24(22):16258 [Crossref]

2- Kalisch-Smith J, Ved N, Sparrow D. Environmental Risk Factors for Congenital Heart Disease. Cold Spring Harb Perspect Biol. 2020;12(3):a037234 [Crossref]

3- Andersen J, Futtrup T. Drugs in pregnancy. 2020;321(1):1243 [Crossref]

4- Manfredini M, Di Castri L, Grandi G. Let’s reconsider modern progestin-only pills during isotretinoin and retinoid therapy. The European Journal of Contraception & Reproductive Health Care. 2024;29(2):37 [Crossref]

5- Hosseinpour P, Gholamabbas G, Pezeshkian F, Erfani A, Shahriarirad R, Parhizkar A. Practice and attitude of general practitioners towards initiating isotretinoin for acne vulgaris in Fars province, Iran: cross-sectional study. BMC Prim Care. 2024;25(1) [Crossref]

6- Altıntaş Aykan D, Ergün Y. Isotretinoin: Still the cause of anxiety for teratogenicity. Dermatologic Therapy. 2020;33(1) [Crossref]

7- Havet A, Bouvard C, Moskal A, Chanelière M, Massardier J, Lebrun‐Vignes B, Jonville‐Bera A, Payet C, Viprey M. Compliance with the pregnancy prevention program among women initiating isotretinoin treatment between 2014 and 2021: A nationwide cohort study on the French Health Data System (SNDS). Acad Dermatol Venereol. 2024; [Crossref]

8- Del Carmen Navarrete‐Mondragón R, Cortés‐Benítez F, Elena Mendieta‐Wejebe J, González‐Andrade M, Pérez‐Villanueva J. Virtual and in Vitro Screening Employing a Repurposing Approach Reveal 13‐cis‐Retinoic Acid is a PTP1B Inhibitor. ChemMedChem. 2024;19(23) [Crossref]

9- Durán C, Riera-Arnau J, Abtahi S, Pajouheshnia R, Hoxhaj V, Gamba M, Alsina E, Martin-Perez M, Garcia-Poza P, Llorente-Garcia A, Gonzalez-Bermejo D, Ibánez L, Sabaté M, Vidal X, Ballarín E, Sanfélix-Gimeno G, Rodríguez-Bernal C, Peiró S, García-Sempere A, Sanchez-Saez F, Ientile V, Ingrasciotta Y, Guarneri C, Tanaglia M, Tari M, Herings R, Houben E, Swart-Polinder K, Holthuis E, Huerta C, Gini R, Roberto G, Bartolini C, Paoletti O, Limoncella G, Girardi A, Hyeraci G, Andersen M, Kristiansen S, Hallgreen C, Klungel O, Sturkenboom M. Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis. Front Pharmacol. 2023;14 [Crossref]

10- Carmody K, Rouse M, Nolan D, Quinlan D. GPs’ practice and attitudes to initiating isotretinoin for acne vulgaris in Ireland: a cross-sectional questionnaire survey in primary care. Br J Gen Pract. 2020;70(698):e651 [Crossref]

11- Al-Mekhlafi R, Attiyah R, Haddad Y, Salah L, Gbolade B. Awareness on Teratogenic Effects of Isotretinoin and Compliance with Precautionary Measures among Women of Childbearing Age in Makkah Province, Saudi Arabia. Obstetrics and Gynecology International. 2021;2021:1 [Crossref]

12- Oliveira C, Almeida L, Bonamigo R, Lima C, Bagatin E. Consensus on the therapeutic management of rosacea – Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia. 2020;95:53 [Crossref]

13- Al-Sheyab R, Alshiyab D, Al-Shagarin R, Murshidi R, ALSalamat H, Abu-Rayyan H, Abu-Arja Y, Ghunaim S, Altamimi S. Prescribing Patterns of Isotretinoin for Acne Among Dermatologists in Central Jordan. 2024; [Crossref]

14- Bastos Maia S, Rolland Souza A, Costa Caminha M, Lins da Silva S, Callou Cruz R, Carvalho dos Santos C, Batista Filho M. Vitamin A and Pregnancy: A Narrative Review. Nutrients. 2019;11(3):681 [Crossref]